JPMorgan Chase & Co’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$740K Sell
164,055
-83,387
-34% -$376K ﹤0.01% 3879
2025
Q1
$1.1M Buy
247,442
+149,782
+153% +$664K ﹤0.01% 3598
2024
Q4
$765K Buy
97,660
+67,325
+222% +$527K ﹤0.01% 3945
2024
Q3
$399K Buy
30,335
+2,854
+10% +$37.5K ﹤0.01% 4150
2024
Q2
$332K Sell
27,481
-3,687
-12% -$44.5K ﹤0.01% 4040
2024
Q1
$507K Sell
31,168
-10,196
-25% -$166K ﹤0.01% 3949
2023
Q4
$282K Buy
41,364
+8,841
+27% +$60.3K ﹤0.01% 4216
2023
Q3
$177K Sell
32,523
-6,000
-16% -$32.7K ﹤0.01% 4293
2023
Q2
$262K Sell
38,523
-156,912
-80% -$1.07M ﹤0.01% 4132
2023
Q1
$979K Buy
195,435
+162,752
+498% +$815K ﹤0.01% 3466
2022
Q4
$160K Sell
32,683
-1,296
-4% -$6.35K ﹤0.01% 4305
2022
Q3
$491K Buy
33,979
+1,315
+4% +$19K ﹤0.01% 3765
2022
Q2
$494K Sell
32,664
-9,658
-23% -$146K ﹤0.01% 3876
2022
Q1
$503K Buy
42,322
+4,752
+13% +$56.5K ﹤0.01% 3986
2021
Q4
$610K Buy
37,570
+1,690
+5% +$27.4K ﹤0.01% 3952
2021
Q3
$1.02M Buy
35,880
+461
+1% +$13.2K ﹤0.01% 3590
2021
Q2
$1.2M Buy
35,419
+3,503
+11% +$118K ﹤0.01% 3538
2021
Q1
$965K Buy
31,916
+1,909
+6% +$57.7K ﹤0.01% 3683
2020
Q4
$1.49M Buy
30,007
+325
+1% +$16.1K ﹤0.01% 3155
2020
Q3
$1.2M Sell
29,682
-1,754
-6% -$71K ﹤0.01% 3013
2020
Q2
$1.36M Sell
31,436
-1,035
-3% -$44.7K ﹤0.01% 2870
2020
Q1
$847K Sell
32,471
-1,762
-5% -$46K ﹤0.01% 3032
2019
Q4
$1.07M Sell
34,233
-963
-3% -$30.1K ﹤0.01% 3032
2019
Q3
$917K Buy
35,196
+2,007
+6% +$52.3K ﹤0.01% 3104
2019
Q2
$739K Buy
33,189
+3,115
+10% +$69.4K ﹤0.01% 3192
2019
Q1
$788K Sell
30,074
-1,249
-4% -$32.7K ﹤0.01% 3148
2018
Q4
$637K Buy
31,323
+1,298
+4% +$26.4K ﹤0.01% 3271
2018
Q3
$798K Buy
+30,025
New +$798K ﹤0.01% 3280